CD44 and familial pancreatic carcinoma: Here, we studied the function of CD44 in pancreatic cancer progression and prognosis and found that the expression of one splicing variant, CD44V3, instead of CD44, was significantly increased in tumor tissues, and its level correlated with poor prognosis.